Standard Pen Needles Market Size to Hit USD 3.82 Billion by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Standard Pen Needles Market

5.1. COVID-19 Landscape: Standard Pen Needles Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Standard Pen Needles Market, By Needle Size

8.1. Standard Pen Needles Market Revenue and Volume Forecast, by Needle Size

8.1.1. 4 mm

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. 5 mm

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. 6 mm

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. 8 mm

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. 10 mm and above

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Standard Pen Needles Market, By Therapy (Drug Type)

9.1. Standard Pen Needles Market Revenue and Volume Forecast, by Therapy (Drug Type)

9.1.1. Insulin Therapy

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. GLP-1 Therapy

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Growth Hormone Therapy

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Standard Pen Needles Market, By Distribution Channel

10.1. Standard Pen Needles Market Revenue and Volume Forecast, by Distribution Channel

10.1.1. Hospital Pharmacy

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Retail Pharmacy

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Online Pharmacy

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Standard Pen Needles Market, By End-User

11.1. Standard Pen Needles Market Revenue and Volume Forecast, by End-User

11.1.1. Homecare/self–administration

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Diagnostic & Speciality Care

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Hospitals & Clinics

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Standard Pen Needles Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Needle Size

12.1.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.1.3. Market Revenue and Volume Forecast, by Distribution Channel

12.1.4. Market Revenue and Volume Forecast, by End-User

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Needle Size

12.1.5.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.1.5.3. Market Revenue and Volume Forecast, by Distribution Channel

12.1.5.4. Market Revenue and Volume Forecast, by End-User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Needle Size

12.1.6.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.1.6.3. Market Revenue and Volume Forecast, by Distribution Channel

12.1.6.4. Market Revenue and Volume Forecast, by End-User

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Needle Size

12.2.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.2.3. Market Revenue and Volume Forecast, by Distribution Channel

12.2.4. Market Revenue and Volume Forecast, by End-User

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Needle Size

12.2.5.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.2.5.3. Market Revenue and Volume Forecast, by Distribution Channel

12.2.5.4. Market Revenue and Volume Forecast, by End-User

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Needle Size

12.2.6.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.2.6.3. Market Revenue and Volume Forecast, by Distribution Channel

12.2.6.4. Market Revenue and Volume Forecast, by End-User

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Needle Size

12.2.7.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.2.7.3. Market Revenue and Volume Forecast, by Distribution Channel

12.2.7.4. Market Revenue and Volume Forecast, by End-User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Needle Size

12.2.8.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.2.8.3. Market Revenue and Volume Forecast, by Distribution Channel

12.2.8.4. Market Revenue and Volume Forecast, by End-User

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Needle Size

12.3.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.3.3. Market Revenue and Volume Forecast, by Distribution Channel

12.3.4. Market Revenue and Volume Forecast, by End-User

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Needle Size

12.3.5.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.3.5.3. Market Revenue and Volume Forecast, by Distribution Channel

12.3.5.4. Market Revenue and Volume Forecast, by End-User

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Needle Size

12.3.6.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.3.6.3. Market Revenue and Volume Forecast, by Distribution Channel

12.3.6.4. Market Revenue and Volume Forecast, by End-User

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Needle Size

12.3.7.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.3.7.3. Market Revenue and Volume Forecast, by Distribution Channel

12.3.7.4. Market Revenue and Volume Forecast, by End-User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Needle Size

12.3.8.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.3.8.3. Market Revenue and Volume Forecast, by Distribution Channel

12.3.8.4. Market Revenue and Volume Forecast, by End-User

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Needle Size

12.4.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.4.3. Market Revenue and Volume Forecast, by Distribution Channel

12.4.4. Market Revenue and Volume Forecast, by End-User

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Needle Size

12.4.5.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.4.5.3. Market Revenue and Volume Forecast, by Distribution Channel

12.4.5.4. Market Revenue and Volume Forecast, by End-User

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Needle Size

12.4.6.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.4.6.3. Market Revenue and Volume Forecast, by Distribution Channel

12.4.6.4. Market Revenue and Volume Forecast, by End-User

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Needle Size

12.4.7.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.4.7.3. Market Revenue and Volume Forecast, by Distribution Channel

12.4.7.4. Market Revenue and Volume Forecast, by End-User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Needle Size

12.4.8.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.4.8.3. Market Revenue and Volume Forecast, by Distribution Channel

12.4.8.4. Market Revenue and Volume Forecast, by End-User

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Needle Size

12.5.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.5.3. Market Revenue and Volume Forecast, by Distribution Channel

12.5.4. Market Revenue and Volume Forecast, by End-User

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Needle Size

12.5.5.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.5.5.3. Market Revenue and Volume Forecast, by Distribution Channel

12.5.5.4. Market Revenue and Volume Forecast, by End-User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Needle Size

12.5.6.2. Market Revenue and Volume Forecast, by Therapy (Drug Type)

12.5.6.3. Market Revenue and Volume Forecast, by Distribution Channel

12.5.6.4. Market Revenue and Volume Forecast, by End-User

Chapter 13. Company Profiles

13.1. Becton, Dickinson and Company (BD)

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerNeedle Sizeance

13.1.4. Recent Initiatives

13.2. Novo Nordisk A/S

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerNeedle Sizeance

13.2.4. Recent Initiatives

13.3. Ypsomed AG

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerNeedle Sizeance

13.3.4. Recent Initiatives

13.4. Owen Mumford Ltd.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerNeedle Sizeance

13.4.4. Recent Initiatives

13.5. Terumo Corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerNeedle Sizeance

13.5.4. Recent Initiatives

13.6. Embecta Corp

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerNeedle Sizeance

13.6.4. Recent Initiatives

13.7. Cardinal Health

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerNeedle Sizeance

13.7.4. Recent Initiatives

13.8. B. Braun SE

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerNeedle Sizeance

13.8.4. Recent Initiatives

13.9. UltiMed, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerNeedle Sizeance

13.9.4. Recent Initiatives

13.10. Allison Medical, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerNeedle Sizeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The standard pen needles market size is expected to increase from USD 1.72 billion in 2025 to USD 3.82 billion by 2035.

Answer : The standard pen needles market is expected to grow at a compound annual growth rate (CAGR) of around 8.30% from 2026 to 2035.

Answer : The driving factors of the standard pen needles market are the rising diabetes and obesity cases, increasing home-based self-injection, and wider adoption of injectable therapies for long-term disease management.

Answer : North America region will lead the global standard pen needles market during the forecast period 2026 to 2035.